Mirum PharmaceuticalsMEX:MIRM 46 Days Inventory is 79.78 as of Mar. 2026, which is 24% below its 10-year median of 104.39. GuruFocus rates MEX:MIRM with a GF Score™ of 46/100 and a GF Value™ of MXN812.06. The stock has 5 warning signs investors should review. Among 637 Biotechnology companies, Mirum Pharmaceuticals ranks better than 77.08% on this metric.
The historical rank and industry rank for Mirum Pharmaceuticals's Days Inventory or its related term are showing as below:
MEX:MIRM'
s Days Inventory Range Over the Past 10 Years
Min: 82.47 Med: 104.39 Max: 290.2
Current: 82.47
During the past 8 years, Mirum Pharmaceuticals's highest Days Inventory was 290.20. The lowest was 82.47. And the median was 104.39.
MEX:MIRM's Days Inventory is ranked better than 77.08% of 637
companies
in the Biotechnology industry
Industry Median: 183.23
vs MEX:MIRM: 82.47
Mirum Pharmaceuticals's Days Inventory
declined
from Mar. 2025 (89.70) to Mar. 2026 (79.78).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Mirum Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.14.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Mirum Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.16.
Mirum Pharmaceuticals (MEX:MIRM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Mirum Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Mirum Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Mirum Pharmaceuticals Days Inventory Related Terms
Mirum Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for Mirum Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:MIRM vs RYTM, SYRE, PTGX: Days Inventory Comparison
For the Biotechnology subindustry, Mirum Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mirum Pharmaceuticals Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Mirum Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Mirum Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mirum Pharmaceuticals (MEX:MIRM) has a Days Inventory of 79.78 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Mirum Pharmaceuticals and its competitors. This is 24% below median its historical median of 104.39. Over the past decade, Mirum Pharmaceuticals' Days Inventory has ranged from 82.47 to 290.20. According to the industry distribution chart, Mirum Pharmaceuticals ranks #146 out of 637 companies in the Biotechnology industry, placing it in the top 22.9%.
Is Mirum Pharmaceuticals' Days Inventory too high?
Mirum Pharmaceuticals' current Days Inventory of 79.78 is 24% below median its 10-year median of 104.39. Over the past 10 years, this metric has ranged from a low of 82.47 to a high of 290.20. The Biotechnology industry median Days Inventory is 183.23. Mirum Pharmaceuticals' value of 79.78 is 56.5% below this industry median. Based on the distribution chart, Mirum Pharmaceuticals ranks #146 out of 637 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Mirum Pharmaceuticals has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Mirum Pharmaceuticals' Days Inventory compare to RYTM and SYRE?
According to the Biotechnology industry distribution chart, Mirum Pharmaceuticals ranks #146 out of 637 companies for Days Inventory. This places Mirum Pharmaceuticals in the top 23% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.23. Mirum Pharmaceuticals' value of 79.78 is 56.5% below this benchmark. Historically, Mirum Pharmaceuticals' own Days Inventory has ranged from 82.47 to 290.20 over the past decade. While the company's 10-year median is 104.39 vs. the industry median of 183.23, Mirum Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mirum Pharmaceuticals's current Days Inventory of 79.78 is 56.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Mirum Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mirum Pharmaceuticals's current Days Inventory is 79.78, which is 24% below median its own 10-year median of 104.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mirum Pharmaceuticals stock overvalued right now?
Mirum Pharmaceuticals (MEX:MIRM) has a current Days Inventory of 79.78. The stock's GF Value™ is MXN812.06, compared to a current price of MXN1,256.12 — trading 54.7% above its estimated fair value. The current Days Inventory is 79.78, which is 24% below median its 10-year median of 104.39 and 56.5% below the Biotechnology industry median of 183.23. Mirum Pharmaceuticals' overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Mirum Pharmaceuticals (MEX:MIRM), the current Days Inventory is 79.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mirum Pharmaceuticals (MEX:MIRM) Overvalued in 2026?
Based on GuruFocus' analysis, Mirum Pharmaceuticals stock appears to be overvalued.
The current stock price of MXN1,256.12 is trading 54.7% above its estimated GF Value™ of MXN812.06.
Key valuation signals for MEX:MIRM:
Days Inventory: 79.78 (24% below median its 10-year median of 104.39)
GF Value™: MXN812.06 vs. price of MXN1,256.12 (54.7% above fair value)
Industry Position: 56.5% below the Biotechnology median (#146 of 637)
No single metric tells the full story. See the MEX:MIRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
46GF Score
Get the complete analysis for MEX:MIRM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MIRM has been successfully added to your 
